# Merge Bio Therapeutics Corp — Form D

Merge Bio Therapeutics Corp of CAMBRIDGE, MA, a company, filed a Form D exempt-offering notice with the SEC on 2025-09-17. The offering totals $15.0M, of which $5.0M was reported sold. Industry: Other.

## Offering

- Filed: 2025-09-17
- Form: D
- Accession: 0001231919-25-000205
- Industry: Other
- Exemptions: 06b
- Total offering: $15.0M
- Amount sold: $5.0M
- Remaining: $10.0M
- Investors: 1
- Date of first sale: 2025-08-26
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-557706

## Issuer

- Name: Merge Bio Therapeutics Corp
- CIK: 0002086124
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2025
- Address: 1 KENDALL SQUARE, BUILDING 200, CAMBRIDGE, MA, 02139
- Phone: 617-286-2631

## Officers, directors & promoters (9)

| Name | Role | Location |
| --- | --- | --- |
| Steve Liapis | Director | Cambridge, MA |
| Elias Quijano | Director | Cambridge, MA |
| Wesley Wong | Director | Hong Kong, K3 |
| Clinton Hansen | Executive Officer | Bangkok, W1 |
| Wesley Wong | Executive Officer | Hong Kong, K3 |
| Clinton Hansen | Promoter | Bangkok, W1 |
| Mark Lipstein | Promoter | Cambridge, MA |
| Wesley Wong | Promoter | Hong Kong, K3 |
| Darren Yang | Promoter | Cambridge, MA |

## More

- [CIK 2086124 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=2086124&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001231919-25-000205.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.